UMass Medical School

UMass Medical School has been given a major boost in its efforts to start a COVID-19 vaccination corps to help quickly inoculate the public with $435,000 in new funding.

Screenings for breast and prostate cancer fell precipitously during the early months of the coronavirus pandemic, indicating the potential danger health leaders have warned about, with patients potentially not receiving other needed medical care during the health crisis.

A team of researchers at UMass Medical School are working with colleagues to closely monitor the potential spread of new coronavirus strains in the Worcester area.

UMass Medical School will begin enrolling adolescents in a Moderna COVID-19 vaccination trial in early February to make the Worcester college one of 15 such testing sites nationwide.

People are on the move at UMass Medical School, North Central Massachusetts Chamber of Commerce and more.

UMass Medical School Chancellor Dr. Michael Collins and UMass system President Marty Meehan have proposed setting up a volunteer corp of nursing and medical students to vaccinate Massachusetts residents against COVID-19, after the initial rollout of the vaccine has been bumpy.

A new therapeutics company is getting started by three UMass Medical School researchers with $110 million in funding and the use of technology licensed from the Worcester school.

People are on the move at Webster Five, Slowey McManus, RemodelWerks and more.

More than 150 UMass Medical School students are being trained to help quickly administer COVID-19 vaccinations in Worcester.

An autism study center at UMass Medical School in Worcester has joined a learning health network of the national advocacy group Autism Speaks.